Preclinical studies of bryostatin-1 to promote remyelination and repair in multiple sclerosis

The Johns Hopkins University was awarded a $982,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund preclinical studies of Bryostatin-1 to promote remyelination and repair in multiple sclerosis from July 15, 2021 to July 14, 2024. Through this funding, The Johns Hopkins University will investigate medical solutions for the battlefield by conducting applied and advanced biomedical research into Bryostatin-1's potential to treat multiple sclerosis. Specifically, the university will use the $982,500 to support preclinical research exploring Bryostatin-1's ability to promote remyelination and repair nerve sheath damage caused by multiple sclerosis. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative medical research.